Company news from the 07/18/06 News Brief

Share this article:
Santarus, a specialty pharmaceutical company focused on products treating gastrointestinal diseases, has launched a new full-service Web site to coincide with the launch of its new capsule formulation Zegerid, an immediate release oral proton pump inhibitor for nighttime acid control. The site, zegerid.com, was designed and developed by Compass Healthcare Communications.
Share this article:
close

Next Article in Business Briefs

Email Newsletters

More in Business Briefs

Avastin pockets another Priority Review label

It's the second for this cancer drug in two weeks.

Court invalidates some healthcare subsidies

The lawsuit has been wending its way through the courts for a while, and, although it is being deliberated in several other venues, the decision is part of a legal dispute that puts patients in the 36 states offering federal exchanges in limbo.

FDA generic division overhaul kicks in

The Food and Drug Administration has been intent on elevating and reorganizing its office of Generic Drugs since 2012.